New Jersey Cancer Action Center

Last week, legislation that seeks to improve New Jerseyans’ access to biomarker testing was introduced in the Legislature. Biomarker testing helps connect cancer patients to the right treatment at the right time, often resulting in improved outcomes and quality of life. In some cases, biomarker testing may provide information that enables patients to forgo ineffective treatments and eliminate the potentially harmful, life-altering side effects of those treatments, which could also result in reduced health care costs.

January 15, 2024, marked 18 years since the New Jersey Smoke-free Air Act was signed into law. My family and I are proud New Jerseyans and direct beneficiaries of this groundbreaking legislation. I distinctly remember the difference it made in everyday life; clearing the haze from restaurants, commuter trains and businesses made it safer for workers and patrons alike. It is hard for me to imagine returning to a restaurant and sitting through a meal with plumes over my plate, ashtrays at every table or returning to a workplace where smoking is permitted and condoned.

TRENTON, N.J. – March 6, 2024 – As state lawmakers consider proposals that aim to reduce the financial impact of disease on patients and families, a new study from the American Cancer Society (ACS) shows that medical debt is associated with worse health status, more premature deaths and higher

TRENTON, N.J. – February 16, 2024 – Protecting free preventive cancer screenings and reducing the burden of medical debt are the top issues of concern for cancer patients and survivors today, according to a new survey by the American Cancer Society Cancer Action Network (ACS CAN) that asked participants to